Richard Koya to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Richard Koya has written about Dose-Response Relationship, Drug.
Connection Strength
0.028
-
The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations. Clin Cancer Res. 2010 Dec 15; 16(24):6040-8.
Score: 0.017
-
Inhibition of Alzheimer's amyloid-beta peptide-induced reduction of mitochondrial membrane potential and neurotoxicity by gelsolin. Neurobiol Aging. 2005 Jun; 26(6):849-55.
Score: 0.011